Pengaruh Pemberian Infusa Teh Hijau Terhadap Kadar SGOT dan SGPT Pada Mencit Diabetes Melitus yang diinduksi Aloksan
Sari
Kata Kunci
Teks Lengkap:
PDFReferensi
Abolfathi AA, Mohajeri D, Rezaie A, Nazeri M. Protective effects of green tea extract against hepatic tissue injury in streptozotocin-induced diabetic rats. Evidence-based Complement Altern Med. 2012;2012.
Amarapurkar DN, Hashimoto E, Lesmana LA, Sollano JD, Chen PJ, Goh KL. How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences? J Gastroenterol Hepatology. 2007;22(6):788–93.
American Diabetes Association (ADA). Diagnosis and Classificiation of Diabetes Mellitus. 2014:81-90.
Bernatoniene J, Kopustinskiene DM. The Role of Catechins in Cellular Responses to Oxidative Stress. Molecules. 2018;23(4):1–11.
Chen L, Magliano DJ, Zimmet PZ. The worldwide epidemiology of type 2 diabetes mellitus - Present and future perspectives. Nat Rev Endocrinology. 2012;8(4):228–36.
Cusi K. Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: Pathophysiology and clinical implications. Gastroenterology. 2012;142(4):711-725.e6.
Farrell GC, Chitturi S, Lau GKK, Sollano JD. Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region:
Executive summary. J Gastroenterol Hepatology. 2007;22(6):775–7.
Gowda S, Desai PB, Hull V V, Math AAK, Sonal N. Published 22 November 2009 A review on laboratory liver function tests Abstract : Liver. 2009;(November):1–11.
Haidari F, Shahi MM, Zarei M, Rafiei H, Omidian K. Effect of green tea extract on body weight, serum glucose and lipid profile in streptozotocin-induced diabetic rats: A dose response study. Saudi Med J. 2012;33(2):128–33.
Kementerian Kesehatan RI. HASIL UTAMA RISKESDAS 2018. 2018.
Kementerian Kesehatan RI. Situasi dan Analisis Diabetes. 2014;8.
Loomba R, Sanyal AJ. The global NAFLD epidemic. Nat Rev Gastroenterol Hepatology. 2013;10(11):686–90.
Lucchesi I AN, Tavares N, Ii DF, Langoni L, Iii C, Fernando S, et al. MODELS , BIOLOGICAL Diabetes mellitus triggers oxidative stress in the liver of alloxan-treated rats : a mechanism for diabetic chronic liver disease 1. 28(7):502–8.
Maruthupandian A, Mohan V. Antidiabetic , Antihyperlipidaemic and Antioxidant Activity of Oxalis corniculata in Alloxan Induced Diabetic Mice. Int J PharmTech Res. 2011;3(7):1681–7.
Rohilla A, Ali S. Alloxan Induced Diabetes : Mechanisms and Effects. Int J Res Pharm Biomed Sci. 2012;3(2):819–23.
Sajjad F, Minhas LA. Effects of green tea (Camellia Sinensis) on liver function tests of mice on high fat diet. Pakistan J Med Heal Sci. 2014;8(3):550–3.
Saxena T, Arya A, Rathore AJ, Rajak N, Naz S, Shah R. GGT and SGPT - A rising marker in diagnosis of non-alcoholic fatty liver disease. Biomed Pharmacol J. 2014;7(1):277–80.
Sengottuvelu S, Duraisami S, Nandhakumar J, Duraisami R, Vasudevan M. Hepatoprotective activity of Camellia sinensis and its possible mechanism of action. Iran J Pharmacol Ther. 2008;7(1):9–14.
Sharangi AB. Medicinal and therapeutic potentialities of tea (Camellia sinensis L.) - A review. Food Res Int. 2009;42(5–6):529–35.
Shivashankara AR, Rao S, George T, Abraham S, Colin MD, Palatty PL, et al. Tea ( Camellia sinensis L . Kuntze ) as Hepatoprotective Agent : A Revisit. Dietary Interventions in Liver Disease: Foods, Nutrients, and Dietary Supplements. Elsevier; 2019. 183–192 p.
Thapa and Walia. Liver function tests and their interpretation. Gastroenterology. 1958;34(4):675–82.
Vishnoi H, Bodla RB, Kant R. Green Tea (Camellia sinensis) and its antioxidant property: A review. Int J Pharm Sci Res. 2018;9(5):1723–36.
Wang D, Ms QG, Mph TW, Ms FQ, Wang Y. Theanine : the unique amino acid in the tea plant as an oral hepatoprotective agent. 2017;26(130):384–91.
Refbacks
- Saat ini tidak ada refbacks.

Karya ini dilisensikan di bawah Lisensi Internasional Creative Commons Atribusi-NonKomersial-BerbagiSerupa 4.0.


